Cannabis has been caught in a web of control and commodification, sidelined from its potential as a community resource and affordable healthcare cornerstone. This report explores how colonial power, corporate interests, and outdated legal frameworks have shaped cannabis policy in Australia, often to the detriment of patients’ health.
⚖️Duty of Care vs the Harm of Control
Cannabis prohibition compromises the fundamental duty of care owed to patients, undermining principles like the Hippocratic Oath. This report examines how control and commodification have distorted access to cannabis as a community healthcare resource, prioritising profit over patient wellbeing.
Prohibition Business Model
In Australia, Cannabis for medical purposes is legal but tightly regulated. Patients cannot grow their own supply, and prices remain high due to licensing and pharmaceutical distribution. Prohibition sustains a business model where access is restricted, costs are inflated, and profits are prioritised over patient care. Your doctor is now your dealer.
Underground Healthcare
The black market thrives under prohibition, generating billions in tax-free cash. Restrictive laws do not eliminate Cannabis use; they redirect profits into unregulated channels, while patients pay inflated medical prices. Licensed growers leak their produce to recreational users, shifting profits away from accountability and regulation.
The Entourage Effect
Cannabis offers therapeutic benefits through its entourage of cannabinoids. Research highlights its role in managing conditions like PTSD, where endocannabinoid deficiencies impair memory and stress regulation. Yet prohibition blocks affordable access, keeping cannabis classified as “dangerous” despite evidence of medical benefit.
Satire exposes contradictions, but the underlying issue is deadly serious: a health/drug industrial complex that places profit ahead of people, punishes dissent, and contradicts the duty of care ethic.
Where Does All the Money Go?
Law enforcement costs, inflated medical prices, and black market profits all flow from prohibition. Redirecting resources toward regulation and home cultivation would dismantle this model, creating transparency and accountability. Cannabis was sidelined not for health reasons, but because it undermines corporate (Big Pharma) control.
Quality of Life
Millions of Australians could significantly improve their quality of life if THC were descheduled*. Home cultivation would decentralise healthcare, reduce dependency on pharmaceuticals, and empower patients with affordable, natural medicine. This shift would foster community resilience, enhance patient autonomy, and promote holistic wellbeing beyond the constraints of the pharmaceutical industry.
Health Context
Medical sovereignty should mean control of health systems, research, manufacturing, and data, ensuring independence from foreign reliance during crises. Yet, the framing in government and NRF documents leans heavily toward economic opportunity and industrial growth, rather than patient-centred care.
The National Reconstruction Fund Corporation (NRFC) highlights Australia’s history of medical innovation and stresses the need to commercialise innovations to build sovereign manufacturing capacity.
The article explicitly invites “investment-ready proposals” and emphasises jobs, GDP contribution, and export opportunities. Patient outcomes are mentioned, but the dominant narrative is about economic resilience and market growth.
Conclusion
Cannabis prohibition in Australia is not about public safety — it’s about maintaining a profitable business model. Cannabis medicine exists, but at inflated prices and under restrictive laws. Medical sovereignty is marketed like a business pitch, while the reality is that people’s health is the true stake.
Meanwhile, the black market flourishes, and patients are denied affordable, natural healthcare.
Descheduling THC would normalise Cannabis as healthcare, dismantle prohibition economics, and empower communities to grow their own medicine.
Fact-checker Links
- NRF: Building Sovereign Medical Science Capability
- Australian Department of Health: Strengthening Global Health and International Pandemic Response
- Entourage effect
- Removal of cannabis from Schedule I of the Controlled Substances Act
Resources – A curated list of sources, archives, and further reading for those who want to dig deeper.
*Descheduled
Rescheduling vs Descheduling: Rescheduling retains cannabis as a scheduled substance, maintaining legal restrictions and controls. Descheduling removes cannabis entirely from controlled substance classifications, effectively legalising it by eliminating regulatory restrictions, similar to those on alcohol or tobacco. This distinction is crucial for understanding the impacts of policy on access, regulation, and patient outcomes.
Quote on Single Convention’s dated terminology: “It is often observed that the Single Convention was formulated in 1961 and contains terminology that reflects the thinking of that time. Now, it is said, over fifty years later, there is a different understanding of the nature, composition and therapeutic uses and psychoactive effects of cannabis.” — Review of the Narcotic Drugs Act 1967 – Final report (2019), Chapter 5: Key Terms and Concepts in the ND Act.
✨ Topic Cluster
2. Legalisation Pathways & Structural Separation: Examining pathways to Cannabis legalisation, including descheduling, regulatory models, political incentives, and the structural reforms needed for a functional post‑prohibition system.
🏛️ Pillar Content
- Australia’s Road to Full Legalisation — A clear, evidence‑based roadmap to full Cannabis legalisation in Australia, explaining descheduling, roadblocks, terminology, and the path beyond regulated markets.
- Cannabis Pathway Divide After Rescheduling — How rescheduling reshapes the cannabis pathway debate, deepening the split between patented products and herbal whole‑plant medicine.
- Cannabis Policy Follows The Money — From Stoner Sloth to Big Pharma: What Changing Incentives Reveal About Law, Trust, and Reform for Cannabis Policy
- The Dream of Free Weed vs. The Nightmare of Reality — The dream of Cannabis freedom collides with outdated treaties, Big Pharma lobbying, and political reluctance.
- Hemp Seed Laws, Limits, and the Case for Reform — Australia regulates hemp seed as food but treats it as a risk. We explain the laws, compliance pressures, and why national reform is needed.
- The Radical Difference of Cannabis — Cannabis is radically misunderstood. This report explains how misclassification, misinformation, and political inertia shaped its history — and why the ECS changes everything.
- Driving For Change: Zero‑Tolerance With Exemptions — Driving reforms in NSW now accept that Cannabis presence is not impairment, yet still rely on zero‑tolerance with exemptions.
- Understanding Civil Rights — A clear, long‑form guide to how civil rights evolve and erode, covering history, autonomy, workplace rights, and modern structural restrictions.
- The Impairment Myth and Driving Laws — Driving laws fail because Cannabis is misclassified. We dissect the Impairment Myth and reveal how purpose‑based regulation restores clarity.
- How Misclassification Creates Confusion — Misclassification fuels confusion in policy. We explain why the rules don’t fit the plant & how evidence‑based law reform can overcome uncertainty.
📌 Related Reports
- Justice is Broken; Repairs are Long Overdue — Justice is overdue. The Pot Report exposes cracks in Cannabis law reform and the cost of delay to fix a broken system.
- Roadside Drug Test: When Medicine Breaks The Law — Australians have legal access to Cannabis for medical purposes — but roadside drug tests still take away their driver licence. Laws haven’t kept up.
- Fit‑for‑Duty Workplace Drug Testing Failure in Australia — Why impairment‑based testing protects safety better than presence testing in the Australian workplace.
- Medican: Your health is our business — This report explores how colonial power, corporate interests, and outdated legal frameworks have shaped policy, to the detriment of health.
- The Slippery Slope of Hemp Legislation — THC in hemp and the global implications for energy, agriculture, and policy. U.S. hemp laws continue to evolve, reshaping global debates.
- Decriminalisation vs Legalisation: Who Gets Your Money? — Decriminalisation and Legalisation — are often used interchangeably, yet they produce very different outcomes for people and the economy.
- Treaty Troubles Ahead with US Crackdown on Hemp — The treaty the U.S. helped architect is the ultimate legal backstop for prohibition. It treats all THC as controlled substances, without distinction.
- Corporate Dealers in Sheep’s Clothing — Corporate Cannabis wrapped itself in a Sheepshield. Now the patent has expired, tinctures are legal, and the wolf must face the people in its birthday suit.
- How Glass-Steagall Applies To Your Health — The Glass-Steagall Act is a model for the health system to reduce vertical integration.
- Owning the Cancer Treatment and the Plant — How expired patents, failed trials, and active claims still shape the future of cannabis‑based cancer treatment — and what this means for growers.
👉 This Article
Medican: Your health is our business — This report explores how colonial power, corporate interests, and outdated legal frameworks have shaped policy, to the detriment of health.